{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:48:49Z","timestamp":1761176929313,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.tracli.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T19:14:53Z","timestamp":1550862893000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR)"],"prefix":"10.1016","volume":"26","author":[{"given":"V.","family":"Thonier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2019.02.006_bib0135","unstructured":"Syndromes dr\u00e9panocytaires majeurs de l\u2019enfant et de l\u2019adolescent. Protocole national de diagnostic et de soins pour une maladie rare. Janvier 2010\u2013Haute autorit\u00e9 de sant\u00e9. Available from https:\/\/www.has-sante.fr\/portail\/jcms\/c_938884\/fr\/ald-n-10-syndromes-drepanocytaires-majeurs-de-l-adulte."},{"key":"10.1016\/j.tracli.2019.02.006_bib0140","unstructured":"Rapport d\u2019activit\u00e9 h\u00e9movigilance 2016. Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9. D\u00e9cembre 2017. Available from https:\/\/www.ansm.sante.fr\/Mediatheque\/Publications\/Bilans-Rapports-d-activite-Bilans-et-rapports-d-activite#folder_26762."},{"key":"10.1016\/j.tracli.2019.02.006_bib0145","unstructured":"Rapport d\u2019activit\u00e9 h\u00e9movigilance 2017. Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9. D\u00e9cembre 2018. Available from https:\/\/www.ansm.sante.fr\/Mediatheque\/Publications\/Bilans-Rapports-d-activite-Bilans-et-rapports-d-activite#folder_26762."},{"key":"10.1016\/j.tracli.2019.02.006_bib0150","first-page":"254","article-title":"Les particularit\u00e9s de la transfusion sanguine chez l\u2019enfant atteint de dr\u00e9panocytose","volume":"20","author":"Odi\u00e8vre","year":"2017","journal-title":"MT Pediatr"},{"key":"10.1016\/j.tracli.2019.02.006_bib0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjh.14609","article-title":"Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference center","volume":"177","author":"Allali","year":"2017","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.tracli.2019.02.006_bib0160","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.006_bib0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tracli.2017.05.016","article-title":"Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment","volume":"24","author":"Pirenne","year":"2017","journal-title":"Transfusion Clin Biol"},{"key":"10.1016\/j.tracli.2019.02.006_bib0170","series-title":"Les groupes sanguins \u00e9rythrocytaires","first-page":"2015","author":"Bailly","year":"2015"},{"year":"2013","series-title":"Human Blood Groups","author":"Daniels","key":"10.1016\/j.tracli.2019.02.006_bib0175"},{"key":"10.1016\/j.tracli.2019.02.006_bib0180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tracli.2008.10.002","article-title":"Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply","volume":"15","author":"Meunier","year":"2008","journal-title":"Transfus Clin Biol"},{"year":"2012","series-title":"The blood group antigen Facts book (ed)","author":"Reid","key":"10.1016\/j.tracli.2019.02.006_bib0185"},{"key":"10.1016\/j.tracli.2019.02.006_bib0190","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/trf.14633","article-title":"High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients","volume":"58","author":"Floch","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.006_bib0195","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.006_bib0200","unstructured":"International Society of Blood Transfusion (ISBT). Red cell immunogenetics and blood group terminology [Internet]. Amsterdam: ISBT Central Office. Available from http:\/\/www.isbtweb.org\/working-parties\/red-cell-immunogenetics-and-blood-group-terminology\/."},{"key":"10.1016\/j.tracli.2019.02.006_bib0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1537-2995.2009.02382.x","article-title":"Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization","volume":"50","author":"Tournamille","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.006_bib0210","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3324\/haematol.2014.104703","article-title":"Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype","volume":"99","author":"Silvy","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2019.02.006_bib0215","first-page":"72","article-title":"Variant RH alleles and Rh immunisation in patients with sickle cell disease","volume":"13","author":"Sippert","year":"2015","journal-title":"Blood transfusion"},{"key":"10.1016\/j.tracli.2019.02.006_bib0220","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood-2008-03-146415","article-title":"Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders","volume":"112","author":"Higgins","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.02.006_bib0225","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","article-title":"Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells","volume":"46","author":"Hendrickson","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.02.006_bib0230","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.12061","article-title":"Challenges of alloimmunization in patients with haemoglobinopathies","volume":"159","author":"Chou","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.02.006_bib0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/tme.12314","article-title":"Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regions","volume":"26","author":"Zheng","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2019.02.006_bib0240","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.02.006_bib0245","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.02.006_bib0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tmrv.2014.04.008","article-title":"Red blood cell alloimmunization mitigation strategies","volume":"28","author":"Hendrickson","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2019.02.006_bib0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000490858","article-title":"Genotyping in Sickle Cell Disease Patients: The French Strategy","volume":"45","author":"Floch","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2019.02.006_bib0260","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/trf.13611","article-title":"Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients","volume":"56","author":"Ibanez","year":"2016","journal-title":"Transfusion"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782019300345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782019300345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:37:28Z","timestamp":1761129448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782019300345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1246782019300345"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2019.02.006","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR)","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}